20-hydroxy-5,8,11,14-eicosatetraenoic acid and aspirin

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with aspirin in 1 studies

Compound Research Comparison

Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Studies (aspirin)	Trials (aspirin)	Recent Studies (post-2010) (aspirin)
640	13	233	48,947	6,817	13,778

Protein Interaction Comparison

Protein	Taxonomy	aspirin (IC50)
Prostaglandin G/H synthase 1	Bos taurus (cattle)	0.35
Integrin beta-3	Homo sapiens (human)	5
Prostaglandin G/H synthase 1	Ovis aries (sheep)	0.8252
Seed linoleate 13S-lipoxygenase-1	Glycine max (soybean)	1.375
Integrin alpha-IIb	Homo sapiens (human)	5
Prostaglandin G/H synthase 1	Homo sapiens (human)	2.271
Substance-P receptor	Cavia porcellus (domestic guinea pig)	2.4
Prostaglandin G/H synthase 2	Homo sapiens (human)	2.15
Urotensin-2 receptor	Rattus norvegicus (Norway rat)	0.3
4-aminobutyrate aminotransferase, mitochondrial	Rattus norvegicus (Norway rat)	2.4
Gamma-aminobutyric acid receptor subunit alpha-1	Rattus norvegicus (Norway rat)	0.35
Prostaglandin G/H synthase 2	Ovis aries (sheep)	2.4081

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giedraitiene, A; Jakstas, V; Kupstyte, N; Lesauskaite, V; Skipskis, V; Tatarunas, V; Zvikas, V	1

Other Studies

1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and aspirin

Article	Year
The impact of CYP2C192, CYP4F23, and clinical factors on platelet aggregation, CYP4F2 enzyme activity, and 20-hydroxyeicosatetraenoic acid concentration in patients treated with dual antiplatelet therapy. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2017, Volume: 28, Issue:8 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P450 Family 4; Female; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine	2017

Article

Year

The impact of CYP2C19*2, CYP4F2*3, and clinical factors on platelet aggregation, CYP4F2 enzyme activity, and 20-hydroxyeicosatetraenoic acid concentration in patients treated with dual antiplatelet therapy.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2017, Volume: 28, Issue:8

Topics: Adenosine; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P450 Family 4; Female; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine

2017